The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has allowed cheaper, off-brand versions to flourish.
Source link : https://www.washingtonpost.com/business/2024/08/30/mounjaro-zepbound-eli-lilly-weight-loss-drugs/
Author : Daniel Gilbert
Publish date : 2024-08-30 17:41:52
Copyright for syndicated content belongs to the linked Source.
